جست‌وجوی استاد و پژوهشگر

• Nutritional Epidemiology
• Cancer Prevention
• Cardiometabolic Diseases
• +۳ مورد دیگر

Dr. Cordova R. is a researcher at the German Cancer Research Center (DKFZ) , focusing on nutritional epidemiology and cancer risk factors with a particular interest in the interplay between cardiometabolic diseases , body weight dynamics , and chronic disease outcomes . Their work spans large-scale multinational cohort studies including the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank . Research interests include: Role of ultra-processed foods in weight gain and obesity Impact of advanced glycation endproducts (AGEs) on cancer risk Genetic and environmental predictors of adiposity gain Association between socioeconomic position and multimorbidity Dietary patterns and CRC molecular pathways Recent publications analyze: Dicarbonyl compounds and weight regulation Stress-induced glucocorticoids and inflammation PLAG1 fusions in CNS tumors Labs/Tasks: EPIC cohort analysis Physical Activity, Nutrition, Alcohol, Cessation of smoking (PANACEA) study International cancer epidemiology collaborations

• Leukemia
• Biostatistics
• Computational Biology
• +۶ مورد دیگر

Tim Triche, Jr., Ph.D., is an Associate Professor at the Van Andel Institute in the Department of Epigenetics . He earned his A.B. in chemistry from Cornell University , followed by an M.S. in biostatistics and a Ph.D. in statistical genetics from the University of Southern California . Before joining Van Andel in 2017, he was a postdoctoral fellow at USC's Norris Comprehensive Cancer Center focusing on cellular senescence in blood disorders. As a key member of The Cancer Genome Atlas Research Network since 2011 with over a dozen high-impact publications in Nature , Cell , and NEJM , Dr. Triche specializes in epigenetics , biostatistics , and computational biology . His lab develops innovative approaches for pediatric AML research, integrating next-generation sequencing with clinical trial design to improve patient outcomes. His work emphasizes statistical learning for patient stratification, molecular profiling of hematological cancers, and interpretable machine learning in biomedical contexts. He leads the Bioinformatics and Biostatistics Core as faculty advisor and maintains active collaborations across institutions. 2025 Nature Cancer study on developmental heterogeneity in cancer susceptibility 2024 NAR methods paper on BISCUIT multi-omics tools 2023 PLOS One validation of MAX regulation in pituitary adenomas 2022 Nature Metabolism obesity subtyping analysis Scientific contributions include: Chan Zuckerberg Initiative grant (2022) for biomedical computing NCI SPORE grant (2021) as co-recipient Key role in Pediatric AML molecular mapping (2017)

Hamza M. Zaferمشاهده پروفایل

دانشیار

• Red Sea World Studies
• Pre-Modern Knowledge Networks
• Ethiopic Literature
• +۴ مورد دیگر

Hamza M. Zafer is an Associate Professor of Arabian and African languages at the University of Washington, holding a Senior Lecturer position in the Program in African Studies. His research focuses on the languages and literatures of the Red Sea world from the 6th to 16th centuries, emphasizing pre-modern knowledge networks across Ethiopic, Arabic, Coptic, Sabaic, and Syriac traditions. His monograph, *Ecumenical Community*, examines early Muslim communitarianism in the post-Red Sea war context. Dr. Zafer earned his Ph.D. from Cornell University. His research interests span cross-cultural textual exchanges, linguistic anthropology, and the historiography of the Horn of Africa and Arabian Peninsula. His work bridges historical linguistics with socio-cultural analysis, highlighting trans-regional intellectual exchanges. His recent publications (2003–2009) include machine learning applications in bioinformatics, such as tumor classification and gene function prediction, reflecting an interdisciplinary approach. Earlier work (1997–1999) explored AI-driven crossword puzzle generation, showcasing computational creativity. No academic awards or grants are explicitly mentioned in the provided text. He advises no listed students, though his mentorship role in language studies may imply graduate supervision not detailed here. No lab affiliations or future projects are described in the available data.

Michael Beerمشاهده پروفایل

استاد

• Computational Regulatory Genomics
• Bioinformatics
• Systems Biology
• +۴ مورد دیگر

Michael Beer is a Professor of Biomedical Engineering and Genetic Medicine at Johns Hopkins University, affiliated with the McKusick-Nathans Institute of Genetic Medicine and the Department of Biomedical Engineering. His research focuses on computational regulatory genomics, leveraging AI/ML to decode DNA sequence-based gene regulation and its role in development and disease. He holds a PhD from Princeton University and has received awards including the Searle Scholars Award and the Simon Ramo Award. Education: PhD in Astrophysical Sciences, Princeton University, 1995 MA in Astrophysical Sciences, Princeton University, 1991 BSE in Engineering, University of Michigan, 1989 Research Interests: Beer's lab develops computational models to understand enhancer activity, CRISPR-based perturbation, and gene regulatory networks in cancer and disease. They use functional genomics data (ATAC-seq, ChIP-seq, Hi-C) to study regulatory mutations and therapeutic strategies. Key Contributions: Pioneered methods like gkm-SVM for regulatory variant prediction and led ENCODE Consortium efforts. His work bridges machine learning and genomics to model dynamic regulatory networks. Awards: Simon Ramo Award (Thesis in Plasma Physics) DOE Fusion Energy Postdoctoral Fellowship National Science Foundation Graduate Fellowship Searle Scholars Award Johns Hopkins Teaching Excellence Award Lab & Collaborations: Located in the McKusick-Nathans Institute, the lab collaborates with the Ph.D. program in Human Genetics and Genomics. Recent projects include CRISPRi screens and ENCODE grant-funded research on regulatory elements.

Ande M. Rumillaمشاهده پروفایل

استاد

• Molecular Pathology
• Genetic Pathology
• Anatomic Pathology
• +۴ مورد دیگر

Dr. Ande M. Rumilla is a distinguished pathologist at Mayo Clinic in Rochester, Minnesota, specializing in Laboratory Medicine and Pathology with a focus on Anatomic Pathology. She holds appointments in the Mayo Clinic College of Medicine and serves as an active researcher and clinician within the Department of Laboratory Medicine and Pathology. Her educational background includes a BA in Biology from the University of Chicago (1999) and an MD from the University of Illinois College of Medicine at Chicago (2004). She completed her residency training in Anatomic and Clinical Pathology (2008) followed by a fellowship in Molecular Genetic Pathology (2010), all at Mayo Clinic. Dr. Rumilla's research spans molecular pathology, genetic diagnostics, and precision medicine with particular expertise in cancer genomics, molecular diagnostics, and epigenetic analysis. Her work bridges basic science with clinical applications, focusing on developing and validating molecular assays for improved patient care. She has made significant contributions to understanding tumor mutation burden, BRAF/RAS signaling pathways, and molecular characterization of various cancers. Her publication record shows a clear trend toward increasingly sophisticated molecular techniques, from traditional pathology to next-generation sequencing, liquid biopsy analysis, and computational approaches to molecular diagnostics. Recent work emphasizes pan-cancer biomarker detection, methylation disorder classification, and validation of clinical molecular assays. Young Investigator Award from the Association for Molecular Pathology (2009) Dr. Rumilla actively contributes to professional societies including the Association for Molecular Pathology (since 2009), College of American Pathologists, United States and Canadian Academy of Pathology, and American Society for Clinical Pathology. She has participated in developing consensus guidelines for cell-free DNA assay validation, demonstrating leadership in establishing standards for molecular diagnostics. Her collaborative research extends across multiple Mayo Clinic departments and external institutions, reflecting the interdisciplinary nature of modern molecular pathology.

Douglas Eastonمشاهده پروفایل

استاد

• Genetic Epidemiology
• Cancer Genetics
• Breast Cancer Research
• +۵ مورد دیگر

Professor Douglas Easton serves as Director of the Centre for Cancer Genetic Epidemiology within the Department of Public Health and Primary Care at the University of Cambridge. He holds the position of Professor of Genetic Epidemiology and leads one of the world's foremost research groups in cancer genetics with an extraordinary publication record exceeding 219,000 citations and an h-index of 218. His educational background includes: Mathematical and Statistics studies at the University of Cambridge PhD in Genetic Epidemiology at the University of London (1992) Professor Easton's research program has revolutionized our understanding of genetic factors in cancer risk, particularly for breast and ovarian cancers. He established the Cancer Research UK Genetic Epidemiology Unit in 1995 and was awarded his professorship in 2003. His work spans the identification of cancer susceptibility genes (including BRCA1/2, ATM, CHEK2, PALB2), development of statistical methods for genetic epidemiology, and creation of risk prediction models like BOADICEA that are now used clinically worldwide. His research integrates population and family-based studies to characterize genetic variants associated with cancer risk. His most recent publications through 2025 demonstrate continued leadership in adapting risk models for diverse populations, integrating polygenic risk scores into clinical practice, and addressing implementation challenges in personalized cancer prevention. The work shows increasing focus on practical application of risk models in healthcare settings and understanding of risk communication impacts. Notable scientific achievements: Elected Fellow of the Royal Society (2022) CRUK Principal Research Fellow (2001-2011) Development of the widely used BOADICEA risk prediction model Leadership of major international consortia including BCAC, EMBRACE, EMBED, and BRIDGES As an educator, Professor Easton has mentored numerous PhD students and lectured in the MPhil in Epidemiology program. His research is supported by substantial funding that enables coordination of large-scale international studies involving hundreds of institutions worldwide. He continues to actively shape the field of cancer genetic epidemiology through both methodological innovation and practical implementation of risk assessment tools.

Sara O. Vargasمشاهده پروفایل

دانشیار

• Pediatric Pathology
• Pulmonary Pathology
• Interstitial Lung Disease
• +۴ مورد دیگر

Sara O. Vargas is an Associate Professor at Harvard Medical School and a practicing pediatric pathologist at Boston Children's Hospital. She holds an MD from University of Vermont College of Medicine and completed fellowships in Pediatric Pathology and Anatomic/Clinical Pathology. Harvard University (Undergraduate) University of Vermont College of Medicine (Medical School) Boston Children's Hospital (Pediatric Pathology Fellowship) Brigham and Women's Hospital (Anatomic/Clinical Pathology Fellowship) Her research focuses on pediatric pulmonary pathology, interstitial lung disease, and genetic determinants of congenital disorders. She has contributed extensively to understanding pulmonary hypertension mechanisms and imaging protocols for developmental lung conditions. Her recent publications address topics like genetic variants in interstitial lung disease, vascular remodeling in pulmonary hypertension, and multiomic analyses of sudden infant death. She serves as Director of Quality and Patient Safety in the Department of Pathology, which processes over 12,000 surgical pathology cases annually. Dr. Vargas specializes in the intersection of pathology, radiology, and clinical genetics, with particular expertise in: Pediatric pulmonary hypertension Congenital lung malformations Genetic lung disease Post-transplant pathology Interstitial lung disease Pediatric oncologic pathology

Mary Lauren Bentonمشاهده پروفایل

استادیار

• Computational Biology
• Gene Regulation
• Biomedical Informatics
• +۳ مورد دیگر

Dr. Mary Lauren Benton is an Assistant Professor in the Department of Computer Science at Baylor University's College of Engineering and Computer Science. She holds a Ph.D. and M.S. in Biomedical Informatics from Vanderbilt University (2020, 2018) and a B.S.I. in Bioinformatics from Baylor University (2015). Education: Ph.D. (Vanderbilt, 2020), M.S. (Vanderbilt, 2018), B.S.I. (Baylor, 2015) Her research focuses on computational biology and gene regulation, particularly how DNA sequences influence genome function and human disease risk through integrated datasets. Recent work explores enhancer-gene interactions, epigenetic mechanisms, and the application of graph neural networks to genomic problems. Selected publications highlight interdisciplinary trends across genomics (e.g., Cis-regulatory landscapes , CTCF motif accessibility ) and computer science (e.g., Dynamic graph attention , Node classification ).

• Colorectal Cancer
• Pharmacogenetics
• Opioid Treatment
• +۲ مورد دیگر

Eivor Alette Laugsand is an Associate Professor at the Norwegian University of Science and Technology (NTNU), affiliated with the HUNT Research Centre. Her work focuses on pharmacogenetics, symptom management in palliative care, and colorectal cancer research. PhD (2011) from NTNU Medical Student Research Thesis (2008) at NTNU Key research areas include: Pharmacogenetic mechanisms in opioid treatment response Colorectal cancer detection and risk factors Symptom management in advanced cancer patients Application of liquid biopsy for early cancer detection Traumatic brain injury epidemiology Her recent publications emphasize: Colorectal cancer biomarker discovery using liquid biopsy Genetic and environmental risk factors for cancer subtypes Improving pain management protocols in palliative care Understanding sex-specific differences in disease presentation Outreach activities include: Public interviews (2016-2018) Conference presentations (IASGO, SAGES, EAPC) Contributions to evidence-based clinical guidelines

Jessica Haywardمشاهده پروفایل

پژوهشگر

• Veterinary Genetics
• Canine Genetics
• Feline Genetics
• +۵ مورد دیگر

Jessica Hayward is a Senior Research Associate in the Department of Biomedical Sciences at Cornell University's College of Veterinary Medicine. Her research focuses on veterinary genetics, particularly canine, feline, and equine species, using genomic approaches to understand disease traits and develop non-invasive biomarkers. She is affiliated with the Cornell Veterinary Biobank and the Center for Vertebrate Genomics. PhD in Biological Sciences from the University of Auckland (2009) Postdoctoral work at Cornell University (Canine Influenza Virus, later shifting to canine genetics) Her research spans veterinary genetics, bioinformatics, and biomarker development. Key projects include genome-wide association studies for glaucoma, deafness, and cancer in companion animals, alongside developing animal variant classification guidelines. She contributes to computational genomics by improving genotype imputation methods. Recent publications highlight her work on gastric cancer in dogs (2025), variant classification frameworks (2024), and orthopedic trait mapping (2023-2016). Her studies often integrate comparative medicine approaches, linking animal models to human health insights.

Daniel Brewerمشاهده پروفایل

استاد

• Cancer Bioinformatics
• Prostate Cancer
• Genomics
• +۵ مورد دیگر

Professor Daniel Brewer is a leading academic in Medical Bioinformatics and Genomics at the University of East Anglia, specifically within the Norwich Medical School . His roles include heading the Cancer Genetics Team, serving as Deputy Director of the Metabolic Health Research Centre, and leading bioinformatics initiatives in global prostate cancer consortia. Brewer holds a PhD in Computational Biology from University College London and has over a decade of experience in applying large-scale 'omics data to improve clinical outcomes for prostate cancer patients. His research focuses on genomic sequencing studies, cancer subtype classification, biomarker development (e.g., the Prostate Urine Risk score), and the role of bacteria in cancer. Notable contributions include leading the CRUK-ICGC Prostate UK group, expanding it into the Pan-Prostate Cancer Group (PPCG), and developing the SEPATH pipeline for pathogen detection in genomic data. He is also active in teaching, including Problem-Based Learning (PBL) tutoring and supervising 6 PhD students. Brewer has secured grants totaling millions from organizations like Prostate Cancer UK and the National Institute for Health. He chairs the bioinformatics committee for the Prostate UK group and contributes to global initiatives like Genomics England’s 100,000 Genomes Project. His work has yielded over 76 publications in journals like Nature and Science , and he received the 2022 European Urology Oncology SoMe Award. Education: MSci Physics (Imperial College London), MRes Biological Complexity (UCL), PhD Computational Biology (UCL) Key Projects: Leveraging PPCG data for prostate cancer prediction, PURSuiT biomarker validation, bacterial-in-cancer studies Grants: Prostate Cancer UK (£2.5M), Movember Foundation (£1.8M), Big C Appeal (£1.1M) Leadership: Norwich Cancer Research Network (NCRN) founder, UEA Biomedical Review Committee member Brewer’s lab focuses on translating genomic insights into clinical tools, with ongoing efforts to develop diagnostic tests and improve treatment strategies for aggressive prostate cancers.

• Cancer Epidemiology
• Colorectal Cancer Genetics
• Mendelian Randomization
• +۲ مورد دیگر

R. E. Schoen is a Professor in the Division of Cancer Epidemiology at the German Cancer Research Center (DKFZ), affiliated with Heidelberg University's Medical Faculty. With 64 publications documented in the DKFZ database, Schoen maintains an active research program focused on the genetic and epidemiological aspects of colorectal cancer. Schoen's research interests center on cancer epidemiology, particularly the genetics of colorectal cancer, Mendelian randomization studies, gene-environment interactions, and genome-wide association studies. Their work bridges population-level observations with molecular mechanisms to understand cancer etiology. Analysis of Schoen's recent publications (2023-2025) reveals a strong focus on colorectal cancer risk factors, including adiposity relationships, gene-drug interactions with NSAIDs, molecular subtypes, and cross-ancestry genetic studies. The research employs sophisticated methodologies like Mendelian randomization and fine-mapping to establish causal relationships and identify biomarkers. Schoen's scientific contributions include work on proteogenomic analyses identifying GREM1 as a mediator in adiposity-colorectal cancer relationships, fine-mapping studies identifying 136 putative colorectal cancer susceptibility genes across diverse populations, and investigations into how genetic risk modifies the protective effects of menopausal hormone therapy. The research program demonstrates significant collaborative activity, with involvement in large international consortia including the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Schoen's work has substantial implications for cancer prevention strategies and personalized risk assessment approaches.

• Biochemistry and cell biology
• Clinical sciences
• Genetics
• +۳ مورد دیگر

Ismail Moghul is a Research Fellow at University College London (UCL), affiliated with the Institute of Ophthalmology and the Research Department of Cancer Bio. He holds a PhD in Data Science (UCL, 2016–2021), an MSc in Bioinformatics (Queen Mary University of London, 2015–2016), and a BSc in Biomedical Sciences (Queen Mary University of London, 2011–2015). His research focuses on biochemistry, clinical sciences, genetics, ophthalmology, immunology, and computational biology, with a particular emphasis on AI-driven diagnostics, genetic disease mechanisms, and epigenetic analysis. He collaborates internationally on projects such as the Eye2Gene initiative, leveraging deep learning for inherited retinal disease diagnosis. His work spans AI applications in ophthalmic imaging, including fundus autofluorescence analysis and retinal biomarker quantification. He has contributed to tools like Retinograd-AI and aIRDetect, which automate image grading for inherited retinal dystrophies. His research also explores genetic determinants of conditions like Fuchs endothelial corneal dystrophy and age-related macular degeneration, integrating multi-omics data and clinical cohorts. Moghul’s publications highlight advancements in epigenetic profiling, long-read sequencing pipelines, and the development of open-source bioinformatics tools such as GIMMEcpg and ReLayer. His interdisciplinary approach bridges computational methods with clinical challenges, addressing unmet needs in precision medicine and patient-centric care. He advocates for patient co-design in healthcare tools, as seen in his commentary on improving hospital letter comprehension for ophthalmic patients. His contributions span over 30 peer-reviewed articles since 2016, reflecting his expertise in AI, genomics, and translational ophthalmology.

• Genetics
• Cancer Research
• Breast Cancer Genetics
• +۴ مورد دیگر

Kristiina Aittomäki serves as a Supervisor in the Doctoral Programme within the Population Health Research Program Unit at the University of Helsinki, Faculty of Medicine. With an extensive publication record spanning over two decades, she has authored or co-authored 260 publications, demonstrating sustained research productivity through 2025. Her research interests focus primarily on genetics and cancer research , with specific expertise in breast cancer genetics, DNA repair mechanisms, and population-based genomic studies. She has made significant contributions to understanding hereditary cancer syndromes, particularly in the Finnish population context. Analysis of her recent publications reveals a strong emphasis on translational genetic research with clinical applications, particularly in cancer risk assessment and variant classification. Her work frequently involves large-scale collaborative projects like FinnGen, which leverages Finland's unique population structure for genetic discovery. Dr. Aittomäki has participated in significant research projects including the 'Consumer choice and personalized health services in maternal care' (2016-2019), demonstrating her engagement with both basic science and health services research.

• Environmental Toxicology
• Cellular Resilience
• Genetic Buffering
• +۵ مورد دیگر

Andrea Rossi is a Research Group Leader at the Leibniz Institute for Environmental Medical Research (IUF) in Düsseldorf, Germany, where they lead the Environmental Adaptation and Cellular Resilience research group. Their work bridges environmental science and molecular biology, focusing on how pollutants influence cellular resilience and disease expression. The research group collaborates extensively with national and international institutions including Heinrich-Heine-Universität Düsseldorf, Leibniz Institute for Food Systems Biology, and ETH Zürich. Dr. Rossi's research interests center on understanding phenotypic plasticity in monogenic inherited diseases, particularly how environmental pollutants affect cellular resilience and trigger compensatory genetic mechanisms. Their work explores how cellular systems adapt under environmental stress with genetic mutations, develops advanced iPSC models for studying disease mechanisms, and employs whole-genome CRISPR screening to identify novel genetic modifiers. A significant aspect of their research investigates how cellular resilience mechanisms impaired during aging may contribute to age-related diseases. The research group's publications over the past five years demonstrate a strong focus on stem cell technology, genome editing, and environmental toxicology. Their work spans from basic molecular mechanisms to translational applications, with particular emphasis on developing precise genome editing techniques like Prime Editing and improving quality control standards for induced pluripotent stem cells. The research has important implications for understanding environmental influences on genetic diseases and developing new therapeutic approaches. Dr. Rossi's team includes postdocs Stephanie Binder and Jochen Dobner, scientific staff member Marianthi Papadopoulou, several master's students, and technical assistance from Vanessa Baltruschat. Their research is supported by multiple funding sources including the Leibniz Association, German Research Foundation (DFG), AFM Téléthon, and the European Union. The Environmental Adaptation and Cellular Resilience group operates several cutting-edge projects including modeling environmental pollution effects on taste perception using organoids, investigating genetic buffering mechanisms, improving Prime Editing efficiency, analyzing genome editing risks, studying epilepsy in mitochondrial diseases, and enhancing hiPSC quality control standards. These projects employ advanced techniques including iPSC modeling, CRISPR screening, and multi-omics approaches.